Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-06-27

Clinical Trial Update: Effect of Early Versus Late Initiation of Edaravone Dexborneol on Neural Function in Patients With Acute Ischemic Stroke [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating early versus late initiation of edaravone dexborneol on neural function after acute ischemic stroke.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Edaravone Dexborneol

Snippet

Sponsor: Xiangya Hospital of Central South University | Conditions: Ischemic Stroke, Acute, Treatment Outcome | Phase 3 | Status: UNKNOWN